Mark Dmytruk's Insider Trades & SAST Disclosures
Mark Dmytruk's most recent trade in Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A was a trade of 1,244 Class A Common Stock done at an average price of $7.3 . Disclosure was reported to the exchange on April 17, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Mark Dmytruk.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Sale of securities on an exchange or to another person at price $ 7.28 per share. | 17 Apr 2025 | 1,244 | 45,453 | - | 7.3 | 9,060 | Class A Common Stock |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2025 | 1,061 | 46,689 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2025 | 1,061 | 3,184 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2025 | 572 | 45,628 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2025 | 572 | 20,060 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2025 | 454 | 4,068 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2025 | 454 | 44,603 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2025 | 453 | 10,423 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2025 | 453 | 45,056 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2025 | 8 | 46,697 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2025 | 8 | 5,906 | - | - | Class B Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | 13 Mar 2025 | 9,497 | 5,914 | - | - | Class B Common Stock | ||
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | 13 Mar 2025 | 9,497 | 44,149 | - | 0 | Class A Common Stock | ||
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 4,245 | 4,245 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Sale of securities on an exchange or to another person at price $ 7.73 per share. | 03 Mar 2025 | 790 | 34,652 | - | 7.7 | 6,103 | Class A Common Stock |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 572 | 20,632 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 572 | 35,442 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 454 | 4,522 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 454 | 34,417 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 453 | 10,876 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 453 | 34,870 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Sale of securities on an exchange or to another person at price $ 13.44 per share. | 03 Feb 2025 | 740 | 33,963 | - | 13.4 | 9,948 | Class A Common Stock |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 572 | 21,204 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 572 | 34,695 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 454 | 33,670 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 454 | 4,976 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 453 | 11,329 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 453 | 34,123 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 8 | 15,411 | - | - | Class B Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 8 | 34,703 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Sale of securities on an exchange or to another person at price $ 11.72 per share. | 03 Jan 2025 | 645 | 33,216 | - | 11.7 | 7,558 | Class A Common Stock |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 572 | 21,776 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 572 | 33,861 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 453 | 33,289 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 453 | 11,782 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 450 | 5,430 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 450 | 32,836 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Sale of securities on an exchange or to another person at price $ 9.64 per share. | 03 Dec 2024 | 741 | 32,386 | - | 9.6 | 7,146 | Class A Common Stock |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2024 | 572 | 22,348 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2024 | 572 | 33,119 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Dmytruk Mark | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2024 | 484 | 32,094 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Dmytruk Mark | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2024 | 484 | 5,880 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Dmytruk Mark | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2024 | 453 | 12,235 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Dmytruk Mark | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2024 | 453 | 32,547 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Dmytruk Mark | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2024 | 8 | 33,127 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Dmytruk Mark | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2024 | 8 | 15,419 | - | - | Class B Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 1,634 | 6,364 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 1,634 | 31,871 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Sale of securities on an exchange or to another person at price $ 7.58 per share. | 01 Nov 2024 | 1,322 | 31,610 | - | 7.6 | 10,015 | Class A Common Stock |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 572 | 32,896 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 572 | 22,920 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 453 | 32,324 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 453 | 12,688 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 36 | 32,932 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 36 | 15,427 | - | - | Class B Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2024 | 1,634 | 30,383 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2024 | 1,634 | 7,998 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Sale of securities on an exchange or to another person at price $ 8.35 per share. | 03 Oct 2024 | 1,217 | 30,237 | - | 8.4 | 10,163 | Class A Common Stock |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2024 | 572 | 23,492 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2024 | 572 | 31,408 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2024 | 453 | 13,141 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2024 | 453 | 30,836 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2024 | 46 | 15,463 | - | - | Class B Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2024 | 46 | 31,454 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2024 | 1,634 | 28,838 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2024 | 1,634 | 9,632 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Sale of securities on an exchange or to another person at price $ 6.17 per share. | 11 Sep 2024 | 1,148 | 28,749 | - | 6.2 | 7,085 | Class A Common Stock |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2024 | 572 | 24,064 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2024 | 572 | 29,863 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2024 | 453 | 29,291 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2024 | 453 | 13,594 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2024 | 34 | 15,509 | - | - | Class B Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2024 | 34 | 29,897 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 65,449 | 1,109,075 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 65,449 | 450,639 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Sale of securities on an exchange or to another person at price $ 0.29 per share. | 01 Aug 2024 | 63,567 | 1,088,186 | - | 0.3 | 18,244 | Class A Common Stock |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 22,917 | 985,417 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 22,917 | 1,150,117 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 18,125 | 561,875 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 18,125 | 1,127,200 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 1,636 | 622,141 | - | - | Class B Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 1,636 | 1,151,753 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2024 | 65,450 | 516,088 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2024 | 65,450 | 1,050,112 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Sale of securities on an exchange or to another person at price $ 0.33 per share. | 01 Jul 2024 | 49,162 | 1,043,626 | - | 0.3 | 16,027 | Class A Common Stock |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2024 | 22,916 | 1,091,153 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2024 | 22,916 | 1,008,334 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2024 | 18,125 | 1,068,237 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2024 | 18,125 | 580,000 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2024 | 1,635 | 1,092,788 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2024 | 1,635 | 623,777 | - | - | Class B Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 65,448 | 990,848 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 65,448 | 581,538 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Sale of securities on an exchange or to another person at price $ 0.55 per share. | 31 May 2024 | 48,866 | 984,662 | - | 0.5 | 26,827 | Class A Common Stock |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 22,917 | 1,031,250 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 22,917 | 1,031,890 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 18,125 | 598,125 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 18,125 | 1,008,973 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 1,638 | 625,412 | - | - | Class B Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 1,638 | 1,033,528 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings I... | Mark Dmytruk | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 65,450 | 646,986 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges